company background image
SHC logo

Sotera Health NasdaqGS:SHC Stock Report

Last Price

US$10.51

Market Cap

US$3.0b

7D

1.6%

1Y

-6.8%

Updated

13 Apr, 2025

Data

Company Financials +

Sotera Health Company

NasdaqGS:SHC Stock Report

Market Cap: US$3.0b

SHC Stock Overview

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. More details

SHC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance1/6
Financial Health2/6
Dividends0/6

Sotera Health Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sotera Health
Historical stock prices
Current Share PriceUS$10.51
52 Week HighUS$17.08
52 Week LowUS$9.53
Beta1.89
1 Month Change-9.32%
3 Month Change-19.71%
1 Year Change-6.83%
3 Year Change-51.70%
5 Year Changen/a
Change since IPO-58.13%

Recent News & Updates

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Mar 31
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Mar 07
There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Recent updates

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Mar 31
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Mar 07
There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Some Confidence Is Lacking In Sotera Health Company's (NASDAQ:SHC) P/S

Feb 26
Some Confidence Is Lacking In Sotera Health Company's (NASDAQ:SHC) P/S

Why Sotera Health Company (NASDAQ:SHC) Could Be Worth Watching

Jan 06
Why Sotera Health Company (NASDAQ:SHC) Could Be Worth Watching

Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden

Dec 05
Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden
author-image

Sterigenics' Expansion And Smart Pricing Poised For Sustained Revenue And Margin Growth

Sep 02 Sotera Health's strategic pricing and capacity expansion reflect confidence in maintaining or growing future revenue and net margins, despite economic pressures.

Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sep 02
Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Jun 25
Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Shareholder Returns

SHCUS Life SciencesUS Market
7D1.6%1.0%5.4%
1Y-6.8%-27.3%3.6%

Return vs Industry: SHC exceeded the US Life Sciences industry which returned -27.4% over the past year.

Return vs Market: SHC underperformed the US Market which returned 3.6% over the past year.

Price Volatility

Is SHC's price volatile compared to industry and market?
SHC volatility
SHC Average Weekly Movement7.4%
Life Sciences Industry Average Movement10.5%
Market Average Movement7.7%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market4.0%

Stable Share Price: SHC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SHC's weekly volatility (7%) has been stable over the past year.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
20153,000Michael Petrassoterahealth.com

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets.

Sotera Health Company Fundamentals Summary

How do Sotera Health's earnings and revenue compare to its market cap?
SHC fundamental statistics
Market capUS$2.98b
Earnings (TTM)US$44.34m
Revenue (TTM)US$1.10b

67.2x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHC income statement (TTM)
RevenueUS$1.10b
Cost of RevenueUS$498.15m
Gross ProfitUS$602.30m
Other ExpensesUS$557.96m
EarningsUS$44.34m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.16
Gross Margin54.73%
Net Profit Margin4.03%
Debt/Equity Ratio549.0%

How did SHC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 16:31
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sotera Health Company is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
Luke SergottBarclays
Patrick DonnellyCitigroup Inc